Skip to content

Clinical trials

Phase 3 Pulmonary Disease, Chronic Obstructive trials in New Zealand

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Pulmonary Disease, Chronic Obstructive Phase: Phase 3 Country / region: New Zealand Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20031
20063
20083
20091
20101
20112
20123
20133
20143
20152
20162
20171
20192
20201
20212
20221
20231
20254

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed29
Recruiting4
Terminated3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boehringer Ingelheim10
AstraZeneca7
GlaxoSmithKline5
Novartis3
Pearl Therapeutics, Inc.3
Chiesi Farmaceutici S.p.A.2
Hoffmann-La Roche2
Flinders University1
Mundipharma Research Limited1
Novartis Pharmaceuticals1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Pulmonary Disease, Chronic Obstructive38
Bronchitis, Chronic4
Emphysema2
Lung Diseases2
Asthma1
Bronchial Diseases1
Cardiovascular Diseases1
Dyspnea1
Lung Diseases, Obstructive1
Respiratory Tract Diseases1

Trials

Showing 1 to 25 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.